-
1
-
-
79960062100
-
The emerging relevance of the cysteine protease Cathepsin S in disease
-
Small DM, Burden RE, Scott CJ. The emerging relevance of the cysteine protease Cathepsin S in disease. Clinic Rev Bone Miner Metab 2011; 9: 122-32.
-
(2011)
Clinic Rev Bone Miner Metab
, vol.9
, pp. 122-132
-
-
Small, D.M.1
Burden, R.E.2
Scott, C.J.3
-
2
-
-
79960073695
-
Cysteine protease cathepsins in atherosclerosis and abdominal aortic aneurysm
-
Sjoberg S, Shi GP. Cysteine protease cathepsins in atherosclerosis and abdominal aortic aneurysm. Clinic Rev Bone Miner Metab 2011; 9: 138-47.
-
(2011)
Clinic Rev Bone Miner Metab
, vol.9
, pp. 138-147
-
-
Sjoberg, S.1
Shi, G.P.2
-
3
-
-
82755161948
-
Cysteine cathepsins: From structure function and regulation to new frontiers
-
Turk V, Stoka V, Vasiljeva O, Renko M, Sun T, Turk B, Turk D. Cysteine cathepsins: from structure, function and regulation to new frontiers. Biochim Biophys Acta 2012; 1824: 68-88.
-
(2012)
Biochim Biophys Acta
, vol.1824
, pp. 68-88
-
-
Turk, V.1
Stoka, V.2
Vasiljeva, O.3
Renko, M.4
Sun, T.5
Turk, B.6
Turk, D.7
-
4
-
-
34447636403
-
Do cathepsins play a role in abdominal aortic aneurysm pathogenesis
-
Sukhova GK, Shi GP. Do cathepsins play a role in abdominal aortic aneurysm pathogenesis? Ann N Y Acad Sci 2006; 1085: 161-9.
-
(2006)
Ann N y Acad Sci
, vol.1085
, pp. 161-169
-
-
Sukhova, G.K.1
Shi, G.P.2
-
5
-
-
37249014466
-
Cysteine protease activity in the wall of abdominal aortic aneurysms
-
Abisi S, Burnand KG, Waltham M, Humphries J, Taylor PR, Smith A. Cysteine protease activity in the wall of abdominal aortic aneurysms. J Vasc Surg 2007; 46: 1260-6.
-
(2007)
J Vasc Surg
, vol.46
, pp. 1260-1266
-
-
Abisi, S.1
Burnand, K.G.2
Waltham, M.3
Humphries, J.4
Taylor, P.R.5
Smith, A.6
-
6
-
-
0032145836
-
Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells
-
Sukhova GK, Shi GP, Simon DI, Chapman HA, Libby P. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest 1998; 102: 576-83.
-
(1998)
J Clin Invest
, vol.102
, pp. 576-583
-
-
Sukhova, G.K.1
Shi, G.P.2
Simon, D.I.3
Chapman, H.A.4
Libby, P.5
-
7
-
-
0037362831
-
Deficiency of cathepsin S reduces atherosclerosis in low-density lipoprotein receptor-deficient mice
-
Sukhova GK, Zhang Y, Pan JH, Wada Y, Yamamoto T, Naito M, Kodama T, Tsimikas S, Witztum JL, Lu ML, Sakara Y, Chin MT, Libby P, Shi GP. Deficiency of cathepsin S reduces atherosclerosis in low-density lipoprotein receptor-deficient mice. J Clin Invest 2003; 111: 897-906.
-
(2003)
J Clin Invest
, vol.111
, pp. 897-906
-
-
Sukhova, G.K.1
Zhang, Y.2
Pan, J.H.3
Wada, Y.4
Yamamoto, T.5
Naito, M.6
Kodama, T.7
Tsimikas, S.8
Witztum, J.L.9
Lu, M.L.10
Sakara, Y.11
Chin, M.T.12
Libby, P.13
Shi, G.P.14
-
8
-
-
0036735233
-
Differential expression of cysteine and aspartic proteases during progression of atherosclerosis in apolipoprotein E-deficient mice
-
Jormsjö S, Wuttge DM, Sirsjö A, Whatling C, Hamsten A, Stemme S, Eriksson P. Differential expression of cysteine and aspartic proteases during progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Pathol 2002; 161: 939-45.
-
(2002)
Am J Pathol
, vol.161
, pp. 939-945
-
-
Jormsjö, S.1
Wuttge, D.M.2
Sirsjö, A.3
Whatling, C.4
Hamsten, A.5
Stemme, S.6
Eriksson, P.7
-
9
-
-
84869444979
-
Deficiency of cathepsin S attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice
-
Qin Y, Cao X, Guo J, Zhang Y, Pan L, Zhang H, Li H, Tang C, Du J, Shi G. Deficiency of cathepsin S attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice. Cardiovasc Res 2012; 96: 401-10.
-
(2012)
Cardiovasc Res
, vol.96
, pp. 401-410
-
-
Qin, Y.1
Cao, X.2
Guo, J.3
Zhang, Y.4
Pan, L.5
Zhang, H.6
Li, H.7
Tang, C.8
Du, J.9
Shi, G.10
-
11
-
-
79960150092
-
Cysteinyl cathepsins and mast cell proteases in the pathogenesis and therapeutics of cardiovascular diseases
-
Qin Y, Shi GP. Cysteinyl cathepsins and mast cell proteases in the pathogenesis and therapeutics of cardiovascular diseases. Pharmacol Ther 2011; 131: 338-50.
-
(2011)
Pharmacol Ther
, vol.131
, pp. 338-350
-
-
Qin, Y.1
Shi, G.P.2
-
12
-
-
84877581432
-
Synthesis of proline analogues as potent and selective cathepsin S inhibitors
-
Kim M, Jeon J, Song J, Suh KH, Kim YH, Min KH, Lee KO. Synthesis of proline analogues as potent and selective cathepsin S inhibitors. Bioorg Med Chem Lett 2013; 23: 3140-4.
-
(2013)
Bioorg Med Chem Lett
, vol.23
, pp. 3140-3144
-
-
Kim, M.1
Jeon, J.2
Song, J.3
Suh, K.H.4
Kim, Y.H.5
Min, K.H.6
Lee, K.O.7
-
13
-
-
84918807784
-
-
Jadhav PK, Schiffler MA, Gavardinas K, Kim EJ, Matthews DP, Staszak MA, Coffey DS, Shaw BW, Cassidy KC, Brier RA, Zhang Y, Christie RM, Matter WF, Qing K, Durbin JD, Wang Y, Deng GG. Discovery of cathepsin S inhibitor LY3000328 for the treatment of abdominal aortic aneurysm. 2014.
-
(2014)
Discovery of Cathepsin S Inhibitor LY3000328 for the Treatment of Abdominal Aortic Aneurysm.
-
-
Jadhav, P.K.1
Schiffler, M.A.2
Gavardinas, K.3
Kim, E.J.4
Matthews, D.P.5
Staszak, M.A.6
Coffey, D.S.7
Shaw, B.W.8
Cassidy, K.C.9
Brier, R.A.10
Zhang, Y.11
Christie, R.M.12
Matter, W.F.13
Qing, K.14
Durbin, J.D.15
Wang, Y.16
Deng, G.G.17
-
14
-
-
84864259637
-
Plasma cathepsin S and cystatin C levels and risk of abdominal aortic aneurysm: A randomized population-based study
-
Lv BJ, Lindholt JS, Cheng X, Wang J, Shi GP. Plasma cathepsin S and cystatin C levels and risk of abdominal aortic aneurysm: a randomized population-based study. PLoS ONE 2012; 7: e41813.
-
(2012)
PLoS ONE
, vol.7
, pp. e41813
-
-
Lv, B.J.1
Lindholt, J.S.2
Cheng, X.3
Wang, J.4
Shi, G.P.5
-
15
-
-
84860221877
-
Elastin degradation is associated with progressive aortic stiffening and all-cause mortality in predialysis chronic kidney disease
-
Smith ER, Tomlinson LA, Ford ML, McMahon LP, Rajkumar C, Holt SG. Elastin degradation is associated with progressive aortic stiffening and all-cause mortality in predialysis chronic kidney disease. Hypertension 2012; 59: 973-8.
-
(2012)
Hypertension
, vol.59
, pp. 973-978
-
-
Smith, E.R.1
Tomlinson, L.A.2
Ford, M.L.3
Mc Mahon, L.P.4
Rajkumar, C.5
Holt, S.G.6
-
16
-
-
0025940824
-
Tight-binding inhibition of cathepsin S by cystatins
-
Brömme D, Rinne R, Kirschke H. Tight-binding inhibition of cathepsin S by cystatins. Biomed Biochim Acta 1991; 50: 631-5.
-
(1991)
Biomed Biochim Acta
, vol.50
, pp. 631-635
-
-
Brömme, D.1
Rinne, R.2
Kirschke, H.3
-
17
-
-
0033083688
-
Cathepsin S required for normal MHC class II peptide loading and germinal center development
-
Shi GP, Villadangos JA, Dranoff G, Small C, Gu L, Haley KJ, Riese R, Ploegh HL, Chapman HA. Cathepsin S required for normal MHC class II peptide loading and germinal center development. Immunity 1999; 10: 197-206.
-
(1999)
Immunity
, vol.10
, pp. 197-206
-
-
Shi, G.P.1
Villadangos, J.A.2
Dranoff, G.3
Small, C.4
Gu, L.5
Haley, K.J.6
Riese, R.7
Ploegh, H.L.8
Chapman, H.A.9
-
18
-
-
4143146210
-
Important role of cathepsin S in generating peptides for TAP-independent MHC class i crosspresentation in vivo
-
Shen L, Sigal LJ, Boes M, Rock KL. Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo. Immunity 2004; 21: 155-65.
-
(2004)
Immunity
, vol.21
, pp. 155-165
-
-
Shen, L.1
Sigal, L.J.2
Boes, M.3
Rock, K.L.4
-
19
-
-
0030614844
-
Physicochemical and physiological mechanisms for the effects of food on drug absorption: The role of lipids and pH
-
Charman WL, Porter CJH, Mithani A, Dressman JB. Physicochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. J Pharm Sci 1997; 86: 269-82.
-
(1997)
J Pharm Sci
, vol.86
, pp. 269-282
-
-
Charman, W.L.1
Porter, C.J.H.2
Mithani, A.3
Dressman, J.B.4
-
20
-
-
84866496751
-
Determination of cathepsin S abundance and activity in human plasma and implications for clinical investigation
-
Cox JM, Troutt JS, Knierman MD, Siegel RW, Qian YW, Ackermann BL, Konrad RJ. Determination of cathepsin S abundance and activity in human plasma and implications for clinical investigation. Anal Biochem 2012; 430: 130-7.
-
(2012)
Anal Biochem
, vol.430
, pp. 130-137
-
-
Cox, J.M.1
Troutt, J.S.2
Knierman, M.D.3
Siegel, R.W.4
Qian, Y.W.5
Ackermann, B.L.6
Konrad, R.J.7
-
21
-
-
0033380873
-
Atorvastatin and simvastatin have distinct effects on hydroxy methylglutaryl-CoA reductase activity and mRNA abundance in the guinea pig
-
Conde K, Roy S, Freake HC, Newton RS, Fernandez ML. Atorvastatin and simvastatin have distinct effects on hydroxy methylglutaryl-CoA reductase activity and mRNA abundance in the guinea pig. Lipids 1999; 34: 1327-32.
-
(1999)
Lipids
, vol.34
, pp. 1327-1332
-
-
Conde, K.1
Roy, S.2
Freake, H.C.3
Newton, R.S.4
Fernandez, M.L.5
-
22
-
-
70349462959
-
Pharmacokinetic, pharmacodynamic, and safety profile of a new cholesteryl ester transfer protein inhibitor in healthy human subjects
-
Wolk R, Chen D, Clark RW, Mancuso J, Barclay PL. Pharmacokinetic, pharmacodynamic, and safety profile of a new cholesteryl ester transfer protein inhibitor in healthy human subjects. Clin Pharmacol Ther 2009; 86: 430-7.
-
(2009)
Clin Pharmacol Ther
, vol.86
, pp. 430-437
-
-
Wolk, R.1
Chen, D.2
Clark, R.W.3
Mancuso, J.4
Barclay, P.L.5
-
23
-
-
0034093374
-
Feedback and hormonal regulation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase: The concept of cholesterol buffering capacity
-
Ness GC, Chambers CM. Feedback and hormonal regulation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase: the concept of cholesterol buffering capacity. Proc Soc Exp Biol Med 2000; 224: 8-19.
-
(2000)
Proc Soc Exp Biol Med
, vol.224
, pp. 8-19
-
-
Ness, G.C.1
Chambers, C.M.2
|